BANGKOK (NNT) – AstraZeneca has approved safety standards at Thailand’s vaccine factory and will send the first batch of raw materials for vaccine production in June.

Public Health Minister Anutin Charnvirakul said an AstraZeneca representative had visited the Thai plant and was satisfied with the manufacturing standards. Siam Bioscience is upgrading its plant in Pathum Thani to produce millions of AstraZeneca doses for Thailand and neighboring countries in Southeast Asia.

Meanwhile, the Public Health Ministry will launch a project on Covid-19 vaccine efficiency among people who received the Sinovac or AstraZeneca vaccines to learn more about their ability to build up immunity in the body.

Results of the test project are expected to be known within the next two months and will help shape the government’s vaccine policy for the next 12 months.

Information and Source
Reporter : Paphamon Arayasukawat
Rewriter : Paphamon Arayasukawat
National News Bureau & Public Relations : http://thainews.prd.go.th

About the author

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Sign Up for Our Newsletter

Get notified of our weekly selection of news

You May Also Like

Can sustainable architecture in emerging markets help lower emissions?

Some emerging markets are taking the lead when it comes to sustainable architecture, often by incorporating traditional designs and materials into construction.

Top 50 APAC firms report 21% growth in 2021 aggregate revenue

An analysis of GlobalData’s Company Reports Database reveals that seven companies out of the top 50 reported an increase of over 40% in their revenue and three companies reported a decline of more than 3%. The list included 28 companies from China, all of which, registered year-on-year growth.

JD.com to cease operations in Thailand and Indonesia

Local websites showed JD.com will end its services in Thailand from March 3 and in Indonesia from the end of the same month. Both units will stop taking orders on February 15.